Clinical Trial Update: DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial [Phase 1]

View source ↗

Summary

Phase 1 trial DR-18 for relapsed or persistent acute myeloid leukemia or myelodysplastic syndrome after hematopoietic cell transplantation is currently suspende…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• DR-18

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | Status: SUSPENDED